• A State of the Art facility, built to meet USFDA and EUGMP Standards to manufacture OSD Formulations spread across an area of 90,000 Sq.ft.
• MARS incorporated 15 years of experience into the design of this facility to meet specific cGMP requirements for US and European Markets.
• Commercial production is expected to commence in the second quarter of 2008.
Main Block
- Built up area is 80,000 Sq.ft
- Multi Product Concept
- Designed for Oral Solid Dosage Forms.
- Dedicated Formulation Research & Development
The Facility is designed on multi product concept consisting of
- 3 Granulation areas
- 2 Blending areas
- 5 Compression areas
- 2 Coating areas
- 4 Blister packing areas
- Dedicated module for Capsule manufacturing
- One Bulk packing Line
|